

Episode 4478: Trump Drops Hammer On Pharmaceutical Companies
May 12, 2025
In this intriguing discussion, Donald Trump, the former President known for his bold policies, joins political strategist Jason Miller and physician Mehmet Oz. They tackle the shocking disparities in drug pricing, advocating for fairer healthcare reforms to relieve American consumers. The trio also dives into the implications of shifting global economics, emphasizing the urgent need for preparedness against rising influences from nations like China. Personal anecdotes add depth as they explore strategic decisions impacting both industry and individual well-being.
AI Snips
Chapters
Transcript
Episode notes
Ending U.S. Healthcare Subsidies Abroad
- The U.S. has been subsidizing foreign countries' healthcare by paying much higher drug prices.
- Most favored nation pricing will end this, making drug prices fairer globally and lower in the U.S.
Drug Price Shocker Anecdote
- A businessman paid $88 in London for a weight loss drug, but $1,300 for the same drug in New York.
- The drug companies could not justify the price difference, revealing irrational pricing.
Cutting Out Drug Middlemen
- Cut out the middlemen in drug sales to reduce unnecessary costs.
- Facilitate direct sales of drugs at fair prices to American citizens.